Latest filing published 26 Sept 2026 for OncoZenge AB, €31k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Paul Murtagh: trading record in brief
All filings by Paul Murtagh on record concern OncoZenge AB. We count 3 filings; the first trade dates from 27 August 2026 and the latest from 18 September 2026.
The open-market record is one-sided, with 2 purchases worth €18k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 26 September 2026, the filings show a transaction worth €31k in OncoZenge AB. The most recent open-market purchase was published on 28 August 2026, 72 days ago. Most trades are made public on the day they happen. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul Murtagh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 118,500 shares@ SEK 3.0064.0% of flowBTA (betald tecknad aktie)ISIN SE0015504097FI:csv-b298d54d21e919281ae0
- 20,000 shares@ SEK 5.050.12% mcap18.5% of flowAktieISIN SE0015504097FI:csv-3669c09e81f729583754Canonical exit: 26 Nov 2026 (T+90)
- 18,000 shares@ SEK 5.300.11% mcap17.5% of flowAktieISIN SE0015504097FI:csv-e1e9e5c0bdfb135d51c9Canonical exit: 25 Nov 2026 (T+90)
3 of 3 declarations